PROCEPT BioRobotics Corporation - Common Stock (NQ:PRCT)

Important Notice to Long-Term Shareholders of Aardvark Therapeutics, Inc. (NASDAQ: AARD); and GPGI, Inc., f/k/a CompoSecure, Inc. (NYSE: GPGI); PROCEPT BioRobotics Corporation (NASDAQ: PRCT); and The Simply Good Foods Company (NASDAQ: SMPL): Grabar Law

October 06, 2026

GPGI, Inc., f/k/a CompoSecure, Inc. (NYSE: GPGI); New Era Energy & Digital, Inc. (NASDAQ: NUAI); Power Solutions International, Inc. (NASDAQ: PSIX); and PROCEPT BioRobotics Corporation (NASDAQ: PRCT): Grabar Law Office is Investigating Claims on Your

Performance

52-Week Range 53.9% below 52-week high

17.57

16.6652W Low 38.1152W High

1 Week 11.6% below 1-week high

17.491W Low 19.871W High

PROCEPT BioRobotics Corporation - Common Stock (PRCT) traded between $16.66 and $38.11 over the past 52 weeks and last traded at $17.57, 53.9% below its 52-week high. Over the past week it ranged between $17.49 and $19.87.

Past 12 Months

-10.2%

-9.6%

-8.6%

-30.1%

-42.9%

-48.2%

1W -$2.00

1M -$1.87

3M -$1.65

6M -$7.57

YTD -$13.19

1Y -$16.37

PRCT was -48.2% over the past year, -30.1% over six months, -42.9% year to date, -10.2% in the last week.

12 Months vs Market

PRCT

-48.2%

DIA

+13.0%

SPY

+15.5%

QQQ

+18.3%

IWM

+10.4%

Over the past 12 months PRCT returned -48.2% versus DIA (Dow) +13.0%, SPY (S&P 500) +15.5%, QQQ (Nasdaq 100) +18.3% and IWM (Russell 2000) +10.4%.

Volume & Liquidity 0.84× 3-mo avg

Today 1,199,176 3-mo avg 1.4M

1.6M

1.4M

1.5M

YTD

1.5M

PRCT most recently traded 1,199,176 shares against a 3-month average daily volume of 1.4M.

More News

October 02, 2026

September 29, 2026

Important Notice to Long-Term Shareholders of Doximity, Inc. (NYSE: DOCS); GoDaddy Inc. (NYSE: GDDY); Planet Fitness, Inc. (NYSE: PLNT); and PROCEPT BioRobotics Corporation (NASDAQ: PRCT): Grabar Law Office is Investigating Claims on Your Behalf

September 28, 2026

September 24, 2026

Kaplan Fox Continues to Alert Investors of a Securities Class Action Deadline on September 22, 2026 Against PROCEPT BioRobotics Corporation (NASDAQ: PRCT)

September 22, 2026

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in PROCEPT BioRobotics Corporation of Class Action Lawsuit and Upcoming Deadlines – PRCT

September 22, 2026

From Pomerantz LLP

Kaplan Fox Continues to Alert Investors of PROCEPT BioRobotics Corporation (NASDAQ: PRCT) to a Class Action Deadline on September 22, 2026

September 22, 2026

Important Notice to Long-Term Shareholders of Aardvark Therapeutics, Inc. (NASDAQ: AARD); Beta Bionics, Inc. (NASDAQ: BBNX); PROCEPT BioRobotics Corporation (NASDAQ: PRCT); and The Simply Good Foods Company (NASDAQ: SMPL): Grabar Law Office is

September 22, 2026

Kaplan Fox Encourages PROCEPT BioRobotics Corporation (NASDAQ: PRCT) Investors Seeking Recovery to Contact the Firm Before September 22, 2026

September 21, 2026

PRCT Deadline: Rosen Law Firm Urges PROCEPT BioRobotics Corporation (NASDAQ: PRCT) Stockholders with Losses in Excess of $100K to Contact the Firm for Information About Their Rights

September 21, 2026

From The Rosen Law Firm, P.A.

Via Business Wire

Kaplan Fox Encourages PROCEPT BioRobotics Corporation (NASDAQ: PRCT) Investors Seeking Recovery to Contact the Firm Before September 22, 2026

September 21, 2026

From Kaplan Fox & Kilsheimer, LLP

PRCT Investors Have Opportunity to Lead PROCEPT BioRobotics Corporation Securities Fraud Lawsuit with SBS Law

September 21, 2026

From Schall, Brown & Schwartz LLP

PROCEPT 96 Hour Deadline Alert: Kahn Swick & Foti, LLC Reminds Investors With Losses In Excess Of $100,000 of Deadline in Class Action Lawsuit Against PROCEPT BioRobotics Corporation - PRCT

September 18, 2026

From Kahn Swick & Foti, LLC

Via Business Wire

Kaplan Fox Encourages PROCEPT BioRobotics Corporation (NASDAQ: PRCT) Investors to Contact the Firm Before the Lead Plaintiff Deadline on September 22, 2026

September 18, 2026

Bragar Eagel & Squire, P.C Urges PROCEPT BioRobotics Corporation Investors to Contact the Firm Seeking Lead Plaintiff Role Before September 22nd

September 18, 2026

From Bragar Eagel & Squire

Kaplan Fox Alerts PROCEPT BioRobotics Corporation (NASDAQ: PRCT) Investors to a Securities Fraud Lawsuit – Lead Plaintiff Deadline is September 22, 2026

September 18, 2026

From Kaplan Fox & Kilsheimer, LLP

Kaplan Fox Reminds Investors of PROCEPT BioRobotics Corporation (NASDAQ: PRCT) to a Securities Class Action Deadline - Contact the Firm Before September 22, 2026

September 17, 2026

PROCEPT BioRobotics Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against PROCEPT BioRobotics Corporation - PRCT

September 17, 2026

From SkyMedia, LLC

Kaplan Fox Alerts Investors to an Upcoming Deadline of September 22, 2026 in the PROCEPT BioRobotics Corporation (NASDAQ: PRCT) Securities Class Action

September 17, 2026

PRCT ALERT: Hagens Berman Reminds PROCEPT BioRobotics (PRCT) Investors of the September 22, 2026 Lead Plaintiff Deadline

September 17, 2026

From Hagens Berman

Via Business Wire

PRCT Investors Have Opportunity to Lead PROCEPT BioRobotics Corporation Securities Fraud Lawsuit with SBS Law

September 17, 2026

From Schall, Brown & Schwartz LLP

SHAREHOLDER ALERT Bernstein Liebhard LLP Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against PROCEPT BioRobotics Corporation (PRCT)

September 17, 2026

From Bernstein Liebhard LLP

Kaplan Fox & Kilsheimer LLP Encourages PROCEPT BioRobotics Corporation (NASDAQ: PRCT) Investors to Contact the Firm Before September 22, 2026

September 16, 2026